IX BIOPHARMA LTD.
(SGX: 42C)

iX Biopharma Ltd. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of therapies for the treatment of acute and breakthrough pain, and male erectile dysfunction. Its segments include Specialty Pharmaceutical and Chemical Analysis segments. The Specialty Pharmaceutical segment is engaged in the development, manufacturing and sale of pharmaceutical products. The Chemical Analysis segment is engaged in the provision of laboratory testing services. Its products are Wafermine, which is a sublingual ketamine oral wafer that contains the non-opioid drug for the management of moderate to severe pain; Bnox, which is a sublingual buprenorphine oral wafer that is developed as a formulation for moderate to severe pain; PheoniX, which is used for the treatment of male erectile dysfunction; WaferRest, which is used for the alleviation of jet lag and improving sleep quality, and Wafernyl, which is used for breakthrough cancer pain.

0.019 -

- (-%)
Range 0.019 - 0.019   (-%)
Open 0.019
Previous Close 0.019
Bid Price 0.018
Bid Volume ('000) 355
Ask Price 0.019
Ask Volume ('000) 699.4
Volume ('000) 50.9
Value 967
Remark -
Delayed prices. Updated at 05 Aug 2025 17:03.
Data powered by
View All Events

About IX Biopharma

iX Biopharma Ltd. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of therapies for the treatment of acute and breakthrough pain, and male erectile dysfunction. Its segments include Specialty Pharmaceutical and Chemical Analysis se...
more

Share your investing ideas
Please login to view stock data and analysis